Decreased METTL3 was found correlated with increased tumor size, advancement and metastasis in colorectal cancer (CRC) where METTL3 downregulation activated the MAPK pathway-associated proteins- particularly p38 and ERK resulting in CRC cell proliferation, migration and invasiveness [51]. Here, METTL3 is linked to neoplasm.